For all biomarkers except C1s/C1-INH complex, plasma levels were significantly different in samples taken from COVID-19 patients at study entry (soon after infection or symptom onset; 9 (5–18) days; further referred to as day 0) when compared to healthy controls (Table 1; Figure 2). The gene discussed is SERPING1; the disease is COVID-19.